eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Genzyme Therapeutics
4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1865 405 200
Medical Information e-mail: ukmedinfo@genzyme.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Fax: +44 (0)1865 774 172

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/06/2011
PIL Cerezyme 200 U Powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 01/11/2010 and displayed until 02/06/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 07/09/2010 and displayed until 01/11/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
Updated on 03/08/2009 and displayed until 07/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/01/2009 and displayed until 03/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 06/06/2008 and displayed until 14/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 26/11/2007 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to side-effects
  • Change to dosage and administration
  • Change to storage instructions
  • Change to Further Information section
Updated on 25/08/2006 and displayed until 26/11/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  imiglucerase